Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer

Abstract

Our results reveal systemic immune dysregulation occurring in early NSCLC and demonstrate the correlation between these dysregulations and clinical features. Our findings suggest that systemic immune dysregulation is involved in cancer development and may be a promising candidate for high-risk screening and treatment strategies for early NSCLC.